Navigation Links
The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
Date:7/23/2008

ternational Phase 3 double-blind, placebo-controlled Sorafenib HCC Assessment Randomized Protocol (SHARP) trial evaluated 602 liver cancer patients who had no prior systemic therapy. The primary endpoints of the study included overall survival and time to symptomatic progression in patients administered Nexavar versus those who received placebo. Secondary endpoints included time to progression, disease control rate and safety.

Results were first presented at the American Society of Clinical Oncology in June 2007.

Median overall survival was 10.7 months for patients who received Nexavar compared to 7.9 months for patients who received placebo (HR=0.69; p=0.0006). There was no difference in time to symptomatic progression between patient groups, based on a patient-reported assessment questionnaire.

Median time to tumor progression was 5.5 months with Nexavar versus 2.8 months with placebo (HR=0.58; p=<0.001). The most common drug-related grade 3/4 events in patients receiving Nexavar were diarrhea and hand-foot-skin reaction. No indication of imbalances was observed with regard to serious adverse events between the Nexavar and placebo-treated groups.

"Hepatocellular cancer is the second type of cancer where Nexavar has demonstrated a meaningful clinical benefit," said Dimitris Voliotis, MD, vice president, Nexavar Clinical Development, Bayer HealthCare Pharmaceuticals. "We are pleased that Nexavar is now available to patients suffering from liver cancer in the U.S. and Europe and we continue to work with worldwide regulatory authorities to secure approvals in other regions."

Hepatocellular carcinoma is the most common form of liver cancer and is responsible for about 90 percent of the primary malignant liver tumors in adults. Liver cancer is the sixth most common cancer in the world and the third leading cause of cancer-related deaths globally. More than 600,000 cases of liver cancer are diagnosed worldwide each year (more than 400,0
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals,Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
2. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
3. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
4. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
5. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
6. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
7. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
8. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
9. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014   Vestagen Technical Textiles, ... patient experience at hospitals. The myComfort™ line of patient ... barrier fabric that is fluid repellant, breathable and in ... the growth of bacteria on the fabric i . ... plays in the chain of transmission. We want myComfort ...
(Date:9/16/2014)... Sept. 16, 2014  Synereca Pharmaceutics, Inc. ... orally active drugs that restore or increase ... a $1.4 million convertible debt financing. Accele ... sciences accelerator Accele Biopharma, Inc., led the ... nationally recognized private not-for-profit corporation focused on ...
(Date:9/16/2014)... N.Y. , Sept. 16, 2014 ... the world,s largest provider of health care products ... medical practitioners, announced today that Stanley M. Bergman, Henry ... will participate in a healthcare services panel at ...  Joining Mr. Bergman will be Dr. Stohler, Dean ...
Breaking Medicine Technology:New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 3Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 4Henry Schein To Present At The Leerink Partners Services Roundtable 2
... pharmaceutical products - particularly those that are first-in-class, socially ... not only external disease state communication but also internal ... a product for a new or relatively unknown condition ... the new disease before introducing a new product to ...
... Company (NYSE: LLY ) today announced that the ... a prior ruling by the U.S. District Court for the ... the company,s method-of-use patent on Strattera® (atomoxetine). In the case ... et al, the court ruled in favor of Lilly, ...
Cached Medicine Technology:Building Support for a New Product Through Effective Internal Disease State Communication 2U.S. Court of Appeals Affirms Validity of Lilly's Strattera Patent 2
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 According to ... player David Wilson has retired after aggravating a neck injury ... and was then discovered to have spinal stenosis as well, ... many adults and can lead to symptoms such as back ... play again after surgery to repair the disc, but recently ...
(Date:9/16/2014)... September 16, 2014 According to ... Research "Latin America Home Healthcare Market (By Device ... Devices, Mobility Assist Devices and Medical Supplies; By ... Therapy and Unskilled Home Healthcare Services) - Industry ... - 2020" the Latin American Home Healthcare market ...
(Date:9/16/2014)... 2014 Today The FSH Society, a world ... Evening of Song,” featuring luminary pianist Steven Blier and two-time ... September 29, 2014 at the Tappan Hill Mansion, located on ... FSH Society is proud to welcome Blier, who performs each ... for FSHD research. , FSHD, one of the most prevalent ...
(Date:9/16/2014)... 16, 2014 Luke Sniewski, Claire Robbie ... a 14-month journey around the world to celebrate cultural ... project, titled ‘Million Ways to Live’, will take them ... the healthy lifestyles of amazing, unique and diverse people. ... the documentary series will focus on how individuals apply ...
(Date:9/16/2014)... September 16, 2014 According to a ... global authority in medical device market research, the market ... $750 million in the U.S . and ... PEG placement kits, PEG replacement tubes, DPEJ tubes, PEG/J ... into low-profile balloon tubes, low-profile non-balloon tubes, nasogastric and ...
Breaking Medicine News(10 mins):Health News:NFL Injuries Put Spotlight on Spinal Health 2Health News:NFL Injuries Put Spotlight on Spinal Health 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Health News:Pianist Steven Blier and Grammy Award-Winner Sylvia McNair to Perform Together for FSH Society Benefit 2Health News:Pianist Steven Blier and Grammy Award-Winner Sylvia McNair to Perform Together for FSH Society Benefit 3Health News:Launched by Luke Sniewski and Claire Robbie, Million Ways to Live is an International Documentary Series on Healthy Living in Different Cultures 2Health News:Launched by Luke Sniewski and Claire Robbie, Million Ways to Live is an International Documentary Series on Healthy Living in Different Cultures 3Health News:Over 17 Million Enteral Feeding Device Placement Procedures is Expected to be Performed in the U.S. and Europe in 2020: Market Led by Covidien, Kimberly-Clark and Abbott 2Health News:Over 17 Million Enteral Feeding Device Placement Procedures is Expected to be Performed in the U.S. and Europe in 2020: Market Led by Covidien, Kimberly-Clark and Abbott 3
... passive smoke could face a higher heart disease risk, says ... second hand smoke exposure through levels of a nicotine by-product ... on the participants' recall of exposure. ,However, in ... of Nottingham, and other researchers measured the level of cotinine ...
... linked to many of the same health problems as tobacco ... wheeze, according to a new study by researchers at Yale ... widely used illicit drug in the United States, and abuse ... published in today’s Archives of Internal Medicine. First author Jeanette ...
... treating atrial fibrillation, a common irregular heart rhythm that ... of Medicine in St. Louis have developed and tested ... surgical procedure that has had the best long-term cure ... procedure is termed Cox-maze IV, and the surgeons believe ...
... migrant birds will be outstaying their welcome in north and central ... has called for tougher measures on bird flu prevention, especially in ... this time, there is an increase in transportation of livestock and ... is predominant during this season. , Yin ...
... that aids patients who suffer from persistent iron overload has ... ,Patients suffering from a rare genetic condition or conditions ... Generally these people are given a painful infusion at nights ... ,But the new drug Exjade is an oral ...
... stress hormone cortisol can have positive effects in certain ... cortisol in the bloodstream, can weaken the immune system ... evidence that cortisol given near in time to a ... impact. ,Psychologists are especially interested in what ...
Cached Medicine News:Health News:Long-term Marijuana Smoking Leads to Respiratory Complaints 2Health News:Surgeons Develop Simpler Way to Cure Atrial Fibrillation 2Health News:Extra Cortisol Protects Women’s Mood Under Stres 2
Steinmann Pins are available in six point styles ranging from 5/64 to 3/16 in. diameters, in standard 9 in. (230 mm) lengths with threaded and smooth tips. Material: DePuy certified stainless steel. ...
... is the only approved radiolucent stand-alone implant ... with the proven reliability of the BAK ... System is constructed of radiolucent, carbon-fiber reinforced ... radiologic visualization, providing a new level of ...
... (Western Blot): The Genetic Systems HIV-1 Western ... the detection of antibodies to HIV-1. The solid ... HIV-1 grown in the CEM cell line. Use ... of HLA Class ll antigens, helps reduce cross ...
... HIV-1 RNA Assay (bDNA) delivers unmatched precision and ... providing physicians with viral load values they can ... and at other critical decision points - without ... need more reasons to choose VERSANT HIV bDNA, ...
Medicine Products: